Soluble RANKL (sRANKL)

soluble receptor activator of nuclear factor kappa-B ligand

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Soluble RANKL (sRANKL), covering 2013-06-28 to 2013-06-28. Get the full timeline:

Most recent: Clinical Trial Update: OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism [NA]